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Summary 
P-selectin glycoprotein ligand 1 (PSGL-1) is a mucin- 
like glycoprotein expressed on the surface of myeloid 
cells and serves as the high affinity counterreceptor 
for P-selectin. The PSGL-1 -P-selectin interaction is 
calcium dependent and requires presentation of sialyl- 
Lewis” (sLe”)-type structures on the O-linked glycans 
of PSGL-1. We report here the identification of a non- 
carbohydrate component of the binding determinant 
that is critical for high affinity binding to P-selectin. 
Located within the first 19 amino acids, this anionic 
polypeptide segment contains at least one sulfated ty- 
rosine residue. We propose that this sulfotyrosine- 
containing segment of PSGL-1, in conjunction with 
sLe” presented on O-linked glycans, constitutes the 
high affinity P-selectin-binding site. 
Introduction 
The selectins are a family of calcium-dependent adhesion 
receptors that can mediate the initial “rolling” interaction 
between leukocytes and vascular endothelium prior to IeU- 
kocyte extravasation (Lasky, 1992; Varki, 1994). P-seleC- 
tin, E-selectin, and L-selectin are structurally similar, and 
each can bind to related fucosylated or sialylated tetrasac- 
charide structures (or both), such as sialyl-Lewis” (SLe”) 
or sialyl-Lewis” (Foxall et al., 1992). Additionally, functional 
binding to P- and L-selectin is maintained after the substi- 
tution of sulfate for sialic acid in these oligosaccharides 
(Yuen et al., 1992; Brandley et al., 1993). Despite this 
common binding of sLeX and related structures, it has be- 
come clear that the selectins have distinct adhesion pat- 
terns and different affinities for sLe”-bearing glycoprotein 
ligands (Varki, 1994). 
The human myeloid cell line HL-60 has been shown 
to display sLe%onjugated surface molecules capable of 
binding both P-and E-selectin (Zhou et al., 1991). Protease 
treatment of HL-60 cells abolished the binding of P-selec- 
tin but not E-selectin, suggesting that sLe” alone is in- 
sufficient for P-selectin binding and some additional 
component is required (Larsen et al., 1992). A unique gly- 
coprotein ligand consisting of a homodimer with two disul- 
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fide-linked subunits of apparent molecular mass - 120 
kDa was identified from HL-60 cell membrane extracts 
following affinity purification using immobilized P-selectin 
(Moore et al., 1992). This ligand appears to share identity 
with P-selectin glycoprotein ligand 1 (PSGL-I), a glycopro- 
tein cloned and characterized from an HL-60 cell cDNA 
library by using an expression cloning strategy employing 
P-selectin as a panning reagent (Sako et al., 1993). Coex- 
pressionofthePSGL-1 cDNAwithacDNAencodinga(l,3/ 
1,4)fucosyltransferase (FT3) (Lowe et al., 1990) in COS 
cells produced functional PSGL-1 that binds to P-selectin 
in a calcium-dependent manner. Antibodies raised against 
this recombinant PSGL-1 recognize the major P-selectin- 
binding protein purified from HL-60 cell membranes (Sako 
et al., 1993). PSGL-1 also appears to be the critical cal- 
cium-dependent ligand for E-selectin in HL-60 cells (Asa 
et al., 1995). 
Glycosidase digestion of myeloid and soluble recombi- 
nant forms of PSGL-1 revealed the presence of O-linked 
and N-linked oligosaccharides (Sako et al., 1993; Moore 
et al., 1994). These experiments suggested a key role for 
O-linked, but not N-linked, oligosaccharides in the binding 
to P-selectin. 
At the outset of this study, we sought to identify the 
unique structural features of PSGL-1 that enable specific 
recognition by P-selectin. We began by mapping the IOCa- 
tion of sLe%ontaining O-linked oligosaccharides present 
on PSGL-1 that are essential for its binding to P-selectin. 
Inspection of the amino acids encoded by the cDNA indi- 
cated that the central portion of the extracellular domain of 
PSGL-1 contains 15 decameric repeats that are especially 
rich in prolines and threonines; additional serines and thre- 
onines in proximity of prolines extend from the repeats 
to the amino terminus. Because O-linked oligosaccharide 
attachment sites are often found at serine and threonine 
residues proximal to proline residues in glycoproteins (Wil- 
son et al., 1991), we elected to follow a deletion strategy 
and remove increasing amounts of the putative O-linked 
oligosaccharide attachment sites. This was done by gen- 
erating a series of carboxy-terminal truncated mutants of 
PSGL-1, each of which is fused to a human immunoglobu- 
lin G (IgG) Fc domain. The resulting series of soluble di- 
merit chimeras was used to delineate the minimal do- 
mains required for P- and E-selectin binding. We also 
noted the unusual presence of three potential sites for 
tyrosine sulfation found near the amino terminus of mature 
PSGL-1 (Sako et al., 1993). Using site-directed muta- 
genesis, we have assessed their functional importance in 
P- and E-selectin binding. 
Our results demonstrate that the first 19 amino acids of 
PSGL-1, containing only a single O-linked oligosaccha- 
ride, are capable of binding to P-selectin. We show that 
this region contains at least one sulfated tyrosine residue 
that is necessary for high affinity binding to P-selectin. In 
addition, differential in vitro binding of E- and P-selectin 
is observed with specific mutated forms of PSGL-1. 
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Figure 1. Structure of PSGL-1 Chimeras 
(A) Schematic representation of the chimeric PSGL-I-IgG deletion 
series. The closed bars indicate PSGL-1 segments, and the open bars 
represent IgG segments. Y, amino-terminal tyrosine. Vertical lines de- 
note the approximate number and location of O-linked oligosaccha- 
rides. Vertical lines with closed circles represent locations of potential 
N-linked glycosylation sites. 
(6) Autoradiograph of the series of soluble PSGL-I-IgG chimeras. 
COS cells were transientlytransfected with plasmids encoding SPACE, 
3/4FT, and the chimera. Conditioned medium containing the [%]methi- 
onine-labeled chimeras was precipitated using protein A-Sepharose 
and resolved on SDS-polyacrylamide gels under either reducing or 
nonreducing conditions as indicated. Mock lanes refer to cells 
transfected only with SPACE and 3/4FT plasmids. Numbers on the 
left column correspond to molecular mass markers. 
Results 
Recombinant PSGL-I-Fc Chimeras Are Processed 
and Secreted as Soluble Dimers 
Previously, we have shown that a soluble form of PSGL-1, 
sPSGL-1 .T7, encoding the extracellular amino-terminal 
254 amino acids fused to an epitope tag sequence, is capa- 
ble of binding both P- and E-selectin in a calcium-depen- 
dent fashion (Sako et al., 1993). To define the binding 
epitope for P-selectin, we fused various lengths of the ex- 
tracellular domain of PSGL-1 to the heavy chain CH2-CH3 
region of IgGl (Capon et al., 1989). This chimeric format 
facilitated formation of soluble dimers and enabled rapid 
purification by protein A-Sepharose. 
As shown schematically in Figure 1 A, 253.Fc is the lon- 
gest of these chimeric fusions and, like sPSGL-1 .T7, con- 
tains all potential 0- and N-linked glycosylation sites. The 
shortest chimera, 19.Fc, contains only the first 19 amino 
acids and no N-linked glycosylation sites. Expression plas- 
mids encoding these chimeras were cotransfected into 
COS cells with a plasmid encoding an FT3 enzyme (Lowe 
et al., 1990) and a plasmid encoding a soluble form of 
the paired basic amino acid converting enzyme (PACE) 
(Rehemtula and Kaufman, 1992; Wasley et al., 1993). The 
rationale for including the PACE was predicated on amino- 
terminal amino acid sequencing results. Purified recombi- 
nant PSGL-1 .T7 produced from COS cells yields a peptide 
sequence QATEYE, confirming the utilization of the PACE 
consensus sequence (R. Ettling, H. White, data not 
shown). Therefore, the PACE plasmid was included in the 
cotransfection experiments to ensure complete pro- 
cessing of PSGL-1. Figure 1 B demonstrates that all of the 
truncated forms of PSGL-1 resulting from cotransfections 
in COS cells were secreted as disulfide-linked soluble ho- 
modimers. 
Binding of Truncated PSGL-1 -Fc Chimeras 
to P- and E-Selectin 
Two different assays were used to monitor the binding of 
PSGL-1 constructs to P- and E-selectin. The first of these 
employs soluble chimeric forms of P-selectin or E-selectin 
covalently coupled to agarose beads and measures the 
binding of [35S]methionine-labeled PSGL-1 chimeras. Only 
interactions with sufficient affinity to withstand multiple 
washing steps yield demonstrable binding. The behavior 
in this assay of the longest PSGL-1 construct, 253.Fc, is 
consistent with previous studies of PSGL-I isolated from 
human neutrophils (Moore et al., 1992, 1994; Norgard et 
al., 1993). The protein can be reprecipitated by a poly- 
clonal PSGL-1 antibody after purification on protein 
A-Sepharose and treatment with sialidase, yet no longer 
can be affinity captured by P-selectin (Figure 2A). Experi- 
ments in which a fucosyltransferase enzyme is omitted 
from COS cell cotransfections demonstrate the depen- 
dence of the protein on fucosylation for activity as well 
(Figure 2A). In all experiments, recombinant PSGL-1 mu- 
tants bound to the P-selectin resin are eluted with EDTA 
and EGTA, demonstrating cation (presumably calcium) 
dependence of the interaction. The interaction therefore 
appears to have a dependence on sLeX or a related struc- 
ture. A titration of the amount of 253.Fc-conditioned me- 
dium added into this assay indicates a linear dose re- 
sponse over as much as a 40-fold range, as monitored by 
autoradiography (Figure 2A) and phosphorimager quanti- 
tation. 
Figure 28 shows that each of the truncated forms of 
PSGL-1 binds to P-selectin with sufficient affinity to be 
detected in this assay. Surprisingly, even the 19.Fc chi- 
mera, comprising only the first 19 amino acids of PSGL-1, 
exhibits binding to P-selectin. Phosphorimager analysis 
indicates that binding of the 19.Fc form to P-selectin oc- 
curs to approximately 5% the extent of binding of the 
253.Fc form. For the E-selectin chimera, only the 253.Fc 
and 148.Fc chimeras are observed to bind with compara- 
ble affinity. Trace amounts of the 47.Fc chimera are de- 
tected to bind E-selectin, and the 19.Fc construct demon- 
strates no detectable binding. Essentially identical results 
also are obtained from constructs cotransfected with the 
recently cloned myeloid a(l,3)fucosyltransferase, FT7 (Nat- 
suka et al., 1994; Sasaki et al., 1994) (data not shown). 
In the second assay, CHO cells expressing full-length 
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Figure 2. Selectin Binding Studies of PSGL-1 Chimeras 
(A) Autoradiograph of 253.Fc protein affinity capture experiments. The 
left five lanes show the effect on P-selectin affinity capture of cotrans- 
fection with and without the vector encoding a fucosyltransferase en- 
zyme (3/4FT), as well as the effect of treatment with sialidase. The 
[%]methionine-labeled PSGL-I-IgG chimerawaspurifiedfrom condi- 
tioned medium with protein A-Sepharose (pr. A) prior to treatment 
with sialidase (sial.). The remaining lanes show the effects on P- and 
E-selectin affinitycaptureof incubating various amountsof conditioned 
medium with the capture resin. COS cell-conditioned media con- 
taining the protein were precipitated using selectin-IgG chimeras cou- 
pled to agarose beads, eluted with EDTA and EGTA, and run on SDS- 
polyacrylamide gel under reducing conditions. 
(B) Autoradiograph of PSGL-l-IgG chimera series affinity captured 
by P- and E-selectin and eluted with EDTA and EGTA as above. Num- 
bers on the left column correspond to molecular mass markers. 
(C)Cell binding assay. Microtiter plate wells were coated with purified 
PSGL-I-IgG chimeras or human IgG antibody at 2 pglml and incu- 
bated with ‘H-thymidine-labeled CHO cells expressing membrane- 
bound P-selectin, E-selectin, or negative control (DUKX) cells. 
membrane-bound P- and E-selectin (Larsen et al., 1991) 
were assayed for their binding to microtiter plate wells 
coated with the PSGL-1 chimeras. This assay allows 
multivalent interactions; binding events with intrinsic affini- 
ties as low as the millimolar range therefore can yield de- 
monstrable binding. Figure 2C shows the results of this 
assay. As expected, PSGL-1 chimeras that exhibit activity 
in the higher affinity capture assay also support binding 
in this assay. In addition, the two chimeras that show little 
or no higher affinity binding to E-selectin do support bind- 
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Figure 3. Selectin Binding Studies of PSGL-1 148.Fc Chimera Mu- 
tants 
(A) Autoradiograph of PSGL-l-IgG chimera mutants affinity captured 
by P-selectin or E-selectin by method described in Figure 2A. 
(B) Cell binding assay of PSGL-1-IgG chimera mutants by method 
described in Figure 28. 
ing in this multivalent system. Indeed, in this system the 
47.Fc construct is able to support binding at a level indistin- 
guishable from 253.Fc or 148.F~. Only background levels 
of binding to any of the PSGL-1 chimeras are observed 
for control CHO-DUKX ceils (Figure 2C). Again, similar 
results are observed when cotransfections are carried out 
with FT7 instead of FT3. Taken together, the results from 
these two binding assays demonstrate that even the first 
19 amino-terminal residues of PSGL-1 contain a determi- 
nant important for high affinity P-selectin binding and that 
differential binding of E- and P-selectin could be observed 
among the various PSGL-1 constructs. 
Sulfation, but Not N-Glycosylation, Is Required for 
PSGL-1 Binding to P-Selectin 
The 148.Fc form of PSGL-1 was chosen for the next series 
of studies because it is the shortest chimera that supports 
the higher affinity binding of both P- and E-selectin. To 
confirm directly that N-linked oligosaccharides on PSGL-1 
are not required for selectin binding, we mutated the two 
remaining putative N-linked glycosylation sites within 
148.Fc, producing the mutant H24Q70.148.F~. The cell- 
based binding assay was used to show that this mutant 
remains fully capable of binding to both P- and E-selectin 
(Figure 38). This result confirms previous studies em- 
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Figure 4. Selectin Binding Studies of PSGL-1 19.Fc Chimera Mutants 
(A) Autoradiograph of 19.Fc chimera mutants affinity captured by 
P-selectin, protein A-Sepharose, or conditioned medium (CM), as indi- 
cated above the lanes. Chlorate-treated cells are indicated (CIO;). 
(6) Cell binding assay of 19.Fc chimeras, by method described in 
Figure 28. 
ploying peptide N-glycosidase on both recombinant and 
natural PSGL-1 (Sako et al., 1993; Moore et al., 1994). 
In addition, the present results suggest that the N-linked 
oligosaccharides on PSGL-1 also are not required for 
E-selectin binding. 
Next, we examined whether sulfation of PSGL-1 is im- 
portantfor its binding to P-selectin. A metabolic inhibitor of 
ATP sulfurylase activity, sodium chlorate (Lipmann, 1958), 
was used to prevent sulfation of both natural PSGL-1 on 
myeloid cells and recombinant PSGL-1 in COS cells. Pa- 
pain-treated HL-80 cells were incubated in the presence 
or absence of 50 mM chlorate for 48 hr. Analysis by fluores- 
cence-activated cell sorting, employing fluorescently la- 
beled selectin chimeras, demonstrated a significantly de- 
creased level of P-selectin reactivity with PSGL-1 on the 
surface of chlorate-treated cells. Surface expression of 
PSGL-1 on these cells was confirmed with a fluorescently 
labeled monoclonal antibody to PSGL-1 (data not shown). 
Sodium chlorate treatment of COS cells producing the 
148.Fc protein also yielded PSGL-1 with markedly re- 
duced P-selectin binding (Figure 3B), indicating the im- 
portance of sulfation for PSGL-1 function. In contrast, 
E-selectin binding was completely unaffected by sodium 
chlorate treatment of myeloid cells or COS cells express- 
ing 148.Fc (Figure 38). 
The Critical Sites of PSGL-1 Sulfation Reside 
on the Amino-Terminal Tyrosines 
Because sodium chlorate inhibits both carbohydrate and 
tyrosine sulfation, the sites of critical sulfation could be on 
O-linked oligosaccharides, one or more of these tyrosine 
residues, or both. Since the first 14 residues of PACE- 
processed PSGL-1 contain a region with several potential 
sites of tyrosine sulfation (Huttner and Baeuerle, 1988), the 
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Figure 5. Analysis of Sulfate in PSGL-1 19.Fc Chimeras 
(A) Autoradiograph showing sulfate incorporation into 19.Fc chimera 
proteins. Conditioned medium from cells fad with either [35S]sulfate 
or P5S]methionine, in the presence and absence of sodium chlorate, 
was affinity precipitated using protein A-Sepharose, and the proteins 
were resolved by reducing SDS-polyacrylamide gel electrophoresis. 
(B) Thin-layer electrophoresis to detect tyrosine sulfate. A [%]sulfate- 
labeled and protein A-purified 19.Fc chimera sample was subjected 
to alkaline hydrolysis with barium hydroxide and analyzed by two- 
dimensional gel electrophoresis at pH 1.9 and 3.5. The autoradiograph 
is shown, and the locations of unlabeled tyrosine sulfate (Tyr(S)), threo- 
nine sulfate (Thr(S)), and phenol red (PR) markers are denoted by 
dashed circles. 
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148.Fc chimera was used to create two types of specific 
mutations in the region of putative tyrosine sulfation. An 
internal deletion mutant, AY148.Fc, was created in which 
the seven amino acids from positions 5-l 1 of the mature 
extracellular domain were removed. The deleted region 
contains three putative tyrosine sulfation sites. This mu- 
tant fails to bind P-selectin in either binding assay, yet 
E-selectin binding is fully maintained (Figures 3A and 3B). 
The second mutant, FFFE.148.Fc, replaces ali three tyro- 
sines, at positions 5, 7, and 10, with phenylalanine and 
the aspartic acid at position 11 with a glutamic acid. This 
mutant does show some binding to P-selectin, but only in 
the multivalent assay. The level of binding is similar to 
that found after chlorate treatment of the 148.Fc form (Fig- 
ure 38). Binding to E-selectin in either assay was com- 
pletely unaffected by the quadruple mutation. It should be 
noted that in the lower affinity assay an additional contribu- 
tion of the acidic residues flanking the tyrosines is indi- 
cated (Figure 38). The data therefore suggest that both 
the amino-terminal tyrosines and the flanking acidic resi- 
dues are important specifically for PSGL-1 binding to 
P-selectin but not E-selectin. To determine whether the 
amino-terminal tyrosines of PSGL-1 are sulfated, we uti- 
lized the 19.Fc chimera in further experiments. Expression 
of this protein in the presence of chlorate completely abol- 
ished binding to P-selectin in the higher affinity assay (Fig- 
ure 4A). Control precipitations with protein A-Sepharose 
show that the protein still was synthesized. A triple mutant, 
termed FFF.lS.Fc, also was created to convert each of 
the three tyrosines at positions 57, and 10 into phenylala- 
nines. Figure 4 shows that, as was seen for FFFE.148.Fc 
mutant, this mutant fails to bind P-selectin in the higher 
affinity binding assay. Again, however, a low level of 
binding is observed in the multivalent cell binding assay. 
Interestingly, a significant level of E-selectin binding 
with FFF.lS.Fc is still detected in the cell binding assay 
(Figure 48). 
The residual binding of the FFF.lS.Fc mutant to the 
selectins is likely to be due to an sLe”-modified O-linked 
oligosaccharide at Thr-3 or Thr-18. Omitting the plasmid 
encoding a fucosyltransferase enzyme during COS cell 
transfection yields a 19.Fc molecule unable to support 
P- or E-selectin binding (data not shown). Treatment with 
sialidase also abrogates P-selectin-binding activity(Figure 
4A). We created a mutant (A16.19.Fc) in which an alanine 
residue replaces the threonine at position 16. This mutant 
exhibits a small shift in gel mobility as compared with 
19.Fc, consistent with a loss of oligosaccharide. More- 
over, this mutant is unable to support binding to either 
P- or E-selectin (Figure 4). These data strongly suggest 
that an O-linked oligosaccharide bearing sLex and located 
at Thr-16 also is essential for 19.Fc binding to P- and 
E-selectin. 
Figure 5 provides evidence that sulfation occurs exclu- 
sively on the tyrosines. Examination of [%S]sulfate incor- 
poration by autoradiography shows that far more labeled 
sulfate is incorporated into 19.Fc than into FFF.19.Fc (Fig- 
ure 5A). The small amount of label incorporated in the 
FFF.lS.Fc is comparable with levels observed for other 
unrelated polypeptides fused into the IgG constant region 
(data not show.n) and therefore is likely to represent incor- 
poration into the IgG region rather than into the oligosac- 
charide at Thr-16. Treatment with sodium chlorate at con- 
centrations that inhibit binding to P-selectin also inhibited 
the incorporation of sulfate into the 19.Fc chimera. The 
chlorate effect is specific, as parallel labelings using 
[%S]methionine indicate that synthesis and secretion of 
the chimeras in treated or untreated cells are nearly equiv- 
alent (Figure 5A). 
To confirm directly the presence of sulfated tyrosine, 
[35S]sulfate-labeled 19.Fc protein was excised from an 
SDS gel, subjected to alkaline hydrolysis, and then ana- 
lyzed by two-dimensional thin-layer electrophoresis. Fig- 
ure 58 shows a single spot from the labeled, hydrolyzed 
material that comigrates with a sulfated tyrosine standard. 
At least one sulfated tyrosine therefore is present in 
PSGL-1. 
Discussion 
While several glycoproteins have been reported to bind 
in aspecificfashion to L-selectin (Laskyet al., 1992; Baum- 
hueter et al., 1993; Berg et al., 1993) PSGL-1 is the only 
high affinity P-selectin ligand characterized to date and 
appears to account for all of the high affinity P-selectin- 
binding sites on human neutrophils (Moore et al., 1995). 
Monomeric P-selectin has been reported to bind to 
- 25,000 sites per neutrophil with an apparent Kd of - 70 
nM (Ushiyama et al., 1993). The focus of our work has 
been to determine what structural features of PSGL-1 dif- 
ferentiate its activity from other sialomucins or glycopro- 
teins. 
The results of the mutagenesis studies presented here 
indicate that an anionic amino-terminal peptide segment 
of PSGL-1 provides an essential component for the spe- 
cific high affinity interaction of PSGL-1 with P-selectin. 
This region is comprised of several acidic amino acid resi- 
dues and three tyrosines. Furthermore, sulfation of tyro- 
sine residues within this anionic peptide segment is critical 
for the high affinity binding of P-selectin. This modified 
region alone is insufficient for high affinity binding, but in 
concert with an O-linked oligosaccharide modified by sLeX 
or a related structure it provides the high affinity recogni- 
tion determinant for P-selectin. It is noteworthy that sul- 
fation of O-linked glycans rather than tyrosine residues 
has been shown to be critical for the binding of glycosyla- 
tion-dependent cell adhesion molecule 1 to L-selectin 
(lmai et al., 1993; Hemmerich et al., 1994, 1995; Hemmer- 
ich and Rosen, 1994). 
The profound effect of tyrosine to phenylalanine substi- 
tutions on activity may be due solely to removal of the 
substrate for sulfation or a combination of substrate re- 
moval and functional significance of the tyrosine side 
chain itself. While it is also possible that these mutations 
are acting indirectly, by altering the sLeX modification of 
carbohydrate on the ligand, this is unlikely, since the car- 
bohydrate components of the AY148.Fc, FFFE.148.Fc, 
and FFF.iS.Fc mutants are unchanged in their ability to 
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bind to E-selectin. E-selectin binding indicates the pres- 
ence of functional sLex (or related structures) on the 
O-linked oligosaccharides of these chimeric proteins, as 
only glycoproteins modified with sLex (or related struc- 
tures) exhibit binding to E-selectin in vitro. 
Our studies are based on PSGL-1 produced in COS cells 
in the presence of FT3. The use of the myeloid fucosyltrans- 
ferase, FT7, yields similar results. A potential concern still 
arises that this COS cell-produced PSGL-1 differs sub- 
stantially from the native PSGL-1 found on the surface of 
human neutrophils. While we cannot rule out some struc- 
tural differences in the oligosaccharides, the validity of 
the COS cell-produced material for the type of analysis 
presented here is strongly reinforced by the unique recog- 
nition of the recombinant PSGL-1 by P-selectin. Other neu- 
trophil sialoglycoproteins produced in the analogous man- 
ner fail to show P-selectin binding (Sako et al., 1993). 
Polyclonal antisera raised against COS-produced PSGL-1 
can block the adherence of HL-60 cells to P-selectin in 
vitro (Vachino et al., 1995). Chlorate treatment of HL-60 
cells reduces the level of binding to P-selectin, but not to 
E-selectin. Finally, labeled sulfate is incorporated in PSGL-1 
isolated from human myeloid U937 cells (R. T. C., J. Flan- 
nery, and D. S., unpublished data). Given these similar 
characteristics between native and recombinant PSGL-1, 
we believe that the recombinant PSGL-1 is a valid test 
system and reflects the functional importance of sulfated 
tyrosines in native PSGL-1. 
Previous attempts to assess the molecular determinants 
of P-selectin ligand recognition have yielded data consis- 
tent with unique presentation of oligosaccharides being 
the sole critical component. One hypothesis, proposed by 
McEver and colleagues (Norgard et al., 1993) and ex- 
panded upon in a recent review (Varki, 1994) is that high 
affinity selectin-ligand interactions result from a multiva- 
lent presentation of sLeX-modified oligosaccharides. In the 
specific case of PSGL-1, a “clustered saccharide patch” 
presented by unique high density O-linked oligosaccha- 
rides may be responsible for the observed high affinity 
and specific binding to P-selectin. While the apparent in- 
crease in binding observed between 19.Fc and 148.Fc is 
consistent with the notion that more than one O-linked 
oligosaccharide is required for the full binding activity of 
PSGL-1, this observation is also consistent with the idea 
that the optimal O-linked oligosaccharide is not localized at 
Thr-16. Since the AY148.Fc and FFFE.148.Fc constructs 
contain multiple O-links yet fail to bind to P-selectin, clus- 
tered oligosaccharides alone cannot constitute the high 
affinity recognition epitope. 
The results presented here argue convincingly for a 
multicomponent recognition motif. Figure 6 shows a sche- 
matic model for this interaction in which both a carbohy- 
drate moiety and an anionic sulfated polypeptide near the 
amino terminus are necessary for high affinity binding to 
P-selectin. In contrast, E-selectin binding does not require 
the anionic peptide portion of the PSGL-l-binding deter- 
minant. 
The sulfated anionic region resembles that of other sul- 
fotyrosine-containing proteins, such as glycoprotein Iba 
Figure 6. The Sulfated Peptide Segment in PSGL-1 Is Critical for 
P-Selectin Binding, but Not E-Selectin Binding 
The amino-terminal 19 amino acids of mature (PACE-cleaved) PSGL-1 
are shown. A bulge over residues 4-11 denotes one recognition com- 
ponent, comprising one or more sulfated tyrosines and four acidic 
residues, The structure drawn above position 16 indicates the second 
component, an O-linked oligosaccharide modified with sLe”or possibly 
another sialylated fucosylated structure. Both components are neces- 
saryfor high affinity binding to P-selectin, but only the latter component 
is critical for E-selectin binding. 
(Dong et al., 1994), hirudin (Rydel et al., 1990), and factor 
VIII (Leyte et al., 1991) yet no direct homology of residues 
1-19 of PSGL-1 with any other protein has been found in 
the GenBank or Swissprot protein database. Each of the 
above proteins is involved in a ligand- or receptor-binding 
interaction and requires tyrosine sulfation for full activity. 
It is interesting to note that the mouse homolog of PSGL-1 
also contains a consensus site for tyrosine sulfation at 
the analogous amino-terminal position, as well as several 
acidic residues (Yang et al., submitted). Electrostatic bind- 
ing interactions mediated by the sulfated region of PSGL-1 
are consistent with the recently measured high tensile 
strength of the unimolecular interaction between purified 
P-selectin and PSGL-1 on neutrophils (Alon et al., 1995). 
The exact position and number of sulfation sites, as well 
as the precise structure of thefucosylated oligosaccharide 
at Thr-16, are the subject of ongoing studies. 
The location of the site on P-selectin that interacts with 
the anionic, sulfated amino-terminal region of PSGL-1 re- 
mainsto bedetermined. Several mutagenesisstudiessug- 
gest that a common site exists on P- and E-selectin for 
calcium-dependent carbohydrate binding (Erbe et al., 
1992, 1993; Hollenbaugh et al., 1993; Bajorath et al., 
1994). Crystallographic studies on E-selectin (Graves et 
al., 1994) indicate that the binding site for sLex within the 
lectin domain is very small. Given this data, it seems un- 
likely that the binding site on P-selectin for the sulfated 
peptide closely overlaps the sLex binding site. Two reason- 
able alternatives are, first, a region outside of the sLex- 
binding site but still within the P-selectin lectin domain and, 
second, the P-selectin epidermal growth factor-like do- 
main. The latter possibility is supported by studies indicat- 
ing the P-selectin epidermal growth factor domain to be 
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critical for high affinity binding (Kansas et al., 1994; Gibson 
et al., 1995) and by the fact that this domain is highly 
conserved among species. Additional studies are required 
to define fully the binding sites on P-selectin and resolve 
this issue. 
Lastly, it is interesting to consider the macromolecular 
structure of PSGL-1 in terms of its physiological function. 
Experiments using immunogold electron microscopy have 
indicated that the surface distribution of PSGL-1 on neutro- 
phils is localized at the tips of microvilli (Moore et al., 1995). 
Our data further localize the critical binding sites to the 
amino-terminal segment of PSGL-1. The inclusion of the 
segment from amino acid residues 48-253 did not appreci- 
ablyenhancethe P-selectin-binding propertiesofoursolu- 
ble PSGL-1 chimeras. Yet this segment of PSGL-1, which 
includes the 15 decameric repeats, contains the highest 
density of O-linked oligosaccharides. Mucin domains hav- 
ing closely packed O-linked carbohydrates are postulated 
to form rigid rod-like structures extending outward from 
the cell surface (Jentoff, 1990). It is therefore likely that 
the high density O-linked segment in PSGL-1 serves to 
extend the amino-terminal binding determinants outward 
from the cell surface, where they are readily accessible 
for selectin binding. In this regard, a rapid association rate 
constant for P-selectin has been noted (Lawrence and 
Springer, 1991; Ushiyama et al., 1993). Thus, it is logical 
that the binding determinants are localized at the amino 
terminus. Moreover, at physiological shear stress, this 
configuration is likely to facilitate the efficient tethering 
and rolling of neutrophils along the blood vessel wall. 
Experimental Procedures 
Plasmid Constructions 
The plasmid pED.253.Fc, expressing a P-selectin ligand protein-IgG 
chimera, was generated by restricting plasmid pPL85 (Sako et al., 
1993) with Xbal and Hincll and ligating the purified 950 bp fragment 
to vector pED.Fc. pED.Fc is expression vector pED (Kaufman et al., 
1991) having a cDNA insert encoding the Fc segment of human IgGl 
with an adapter sequence immediately 5’ to the hinge region. The 
fusion of the extracellular portion of PSGL-1 after the valine codon 
295 encodes amino acids LRPQSR DKTHTCPPC at the junction. Plas- 
mid constructs pED.148.Fc, pED.47.Fc, and pED.19.Fc were created 
by standard PCR technique, using pED.253.F~ as template and the 
following pairs of oligonucleotide primers. Universal upstream pri- 
mar: 5’-CCAGGTCCAACTGCAGGTCGACTCTAGAGGGCACTTCTT- 
CTGGGCCCACG. Downstream primer for 148.F~: S-TATTATCT- 
GTGCGGCCGCCCTCCAGAACCCATGGCTGCTGGTTGCAGTGG. 
Downstream primer for 47.Fc: 5’-TATTATCTGTGCGGCCGCGCAG- 
CAGGCTCCACAGTGGTAG. Downstream primer for 19.Fc: 5’-TAT- 
TATCTGTGCGGCCGCGGAGGCTCCGTTTCTGGCAG. PCR prod- 
uct DNA was digested with Pstl and Notl, gel purified, and ligated 
with pED.Fc vector fragment. Correct constructs were identified by 
restriction analysis and confirmed by DNAsequencing. Plasmids pED- 
.AY148.Fc, H24Q70.148.Fc, and A16.19.Fc were created by site- 
directed mutagenesis (Sambrook et al., 1989) using pED.148.F~ or 
pED.lS.Fc as templates. The mutagenesis oligonucleotide for AY148 
was 5’CGGAGACAGGCCACCGAATTCCTGCCAGAAACG. Positive 
colonies were identified by colony hybridization (Sambrook et al., 
1989). The pED.FFFE.148.FC vector was constructed by restricting 
pED.Ay148.F~ with EcoRl and ligating the following annealed oligonu- 
cleotides: 5’-AATTCGAGTTCCTAGATTTTG and 5’AATTCAAAATC 
TAGGAACTCG. The pED.FFF.lS.Fc vector was made by restricting 
pED.Ay148.F~ with EcoRl and Not1 and ligating the following annealed 
oligonucleotides: 5’-AATTCGAGTTCCTAGATTTCGATTTCCTGCCA- 
GAAACTGAGCCTCCGC and 5’-GGCCGCGGAGGCTCAGTTTCTG- 
GCAGGAAATCGAAATCTAGGAACTCG. 
Production and Purification of Selectin Chimeras 
P-selectin cDNA was fused after the encoded fourth consensus repeat 
domain to IgGl Fc to create a soluble P-selectin-IgG chimera in vector 
pED. The resulting expression plasmid was used to establish a stable 
CHO cell line. Secreted chimeras were purified from serum-free me- 
dium by conventional chromatography. E-selectin-IgG chimera was 
constructed by fusing coding sequences of complete extracellular do- 
main of E-selectin with human IgGl Fc of pED.Fc. An Ascl fragment 
containing the fusion cDNA was ligated at polylinker of baculovirus 
vector pVL1393 (Webb and Summers, 1990) creating plasmid 
pVLsE.Fc. Recombinant baculovirus was generated by cotransfecting 
Sf9 cells with 3 ug of pVLsE.Fc plasmid DNA, 1 ug of BaculoGold 
AcMNPV viral DNA (Pharmingen), followed by plaque purification. 
High titer virus (108 pfu/ml) was used to infect Trichoplusia ni High 
Five cells (Invitrogen). The supernatant 72 hr postinfection was col- 
lected, and E-selectin-IgG chimera was affinity purified using protein 
A-Sepharose (Pierce). 
Affinity Capture Assays 
The E-selectin chimera, P-selectin chimera, and human IgGl (Sigma) 
were covalentlycoupled to a gel resin via imide ester-amide exchange 
chemistry (Affi-Gel 15; Bio-Rad) using the protocols of the manufac- 
turer. Plasmid DNAs encoding the various forms of sPSGL-I-Fc chi- 
meras were cotransfected with vectors pEA.3/4FT and pEAsPACE 
into COS cells using the DEAE-dextran technique (Keown et al., 1990) 
and labeled metabolically with [%]methionine. For sulfate incorpora- 
tion experiments, cells were starved for 1 hr in sulfate-free EMEM 
medium (Specialty Media), supplemented with 10% of normal concen- 
trations of cysteine and methionine (Gibco) as well as 100 mM sodium 
chlorate (Fluka). Labeling was carried out for 6-7 hr by adding the 
same medium, supplemented with 5% dialyzed fetal calf serum, 10 
mM HEPES (pH 7.2) and either%-labeled sulfate or methionine (New 
England Nuclear). Control labelings were done in chlorate-free me- 
dium. Conditioned media were collected after labeling, aprotinin and 
sodium azide were added to 0.1% and 0.05%, respectively, and the 
conditioned media then were centrifuged to remove cell debris and 
detached cells. Labeled conditioned media, mixed 1:2 with affinity 
capture buffer (TBS, 5 mglml BSA, 2 mM CaC&, 0.04% Triton X-100, 
and 0.02% sodium azide), were added to affinity resins, and the mix- 
tures were gently inverted overnight at 4%. Resins then were washed 
extensively with BSA-free affinity capture buffer and batch-eluted with 
TBS containing 5 mM EDTA and 5 mM EGTA. 
For control affinity precipitations, protein A-Sepharose 4 fast flow 
(Pharmacia) or a polyclonal rabbit anti-PSGL-I antibody, Rb3443, cou- 
pled to Affi-Gel 10 was used. The antibody was raised against a peptide 
comprising the first 15 amino acids of the mature PSGL-1 amino termi- 
nus. Quantitative analysis was carried out by using ImageQuaNT soft- 
ware and a phosphorimager (Molecular Dynamics). Data were nor- 
malized for differential expression and labeling by using Rb3443 
immunoprecipitation data. 
Cell Binding Assay 
COS cells were transfected with the various PSGL-1-IgG chimera 
plasmids as for the affinity capture assay. Serum-free medium (50 
ml), collected 40-64 hr posttransfection from 1 x 1O’COS cells, was 
purified on a column of 0.25 ml of protein A-Sepharose equilibrated 
with TBS plus 2 mM CaCI,. After washing with 20 ml of TBS plus 2 
mM CaC12, the bound material was eluted with 0.5 ml of 0.1 M acetic 
acid, 0.15 M NaCI, 2 mM CaCl*. The eluted material was neutralized 
with 5% volume of 3 M Tris (pH 9.0) and dialyzed against TBS plus 2 
mM CaCI,, 0.1 mM PMSF. The material was quantitated by measuring 
absorbance at 280 nm and by Coomassie blue staining of SDS-poly- 
acrylamide-Laemmli gels. The protein concentration was adjusted to 
2 pglml prior to assay. 
Microtiter plates (48 well, untreated: Corning) were coated for 16 
hr at 4% with 0.2 ml of purified sPSGL-I-Fc chimeras. The unbound 
material was removed, and the coated wells were treated with Hanks’ 
buffered salt solution with 10 mglml BSA and 2 mM CaCk for 1 hr at 
4%. CHO-P-selectin, CHO-E-selectin, and CHO-DUKX cells(Larsen 
Cell 
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et al., 1992) were labeled by overnight incubation with 3H-thymidine 
(New England Nuclear), and counts per minute per number of ceils 
was recorded. Cells (2 x 105) were added to the prepared microtiter 
plates and incubated for 6 min at room temperature. The plates were 
washed four times with Hanks’ buffered salt solution, 2 mM CaC& 
and trypsinized, and the bound cells were quantitated by scintillation 
counting. 
Sialidase Treatment of PSGL-1 Chimeras 
[%]methionine-labeled 253.Fc or 19.Fc mutant constructs, purified 
from conditioned medium by protein A-Sepharose chromatography, 
were incubated with sialidase from Arthrobacter ureafaciens (Calbio- 
them) in a buffer containing 150 mM NaCI, 60 mM sodium acetate, 
6 mM calcium chloride, and 0.02% Triton X-100 at pH 5.5. After a 16 
hr digestion with 200 mu/ml enzyme at 37OC, the samples were diluted 
into affinity capture buffer, incubated with either P-selectin coupled 
to Affi-Gel 15 or rabbit polyclonal antibody Rb3443 coupled to Affi-Gel 
IO, and processed as described above. 
Alkaline Hydrolysis Treatment of 19.Fc 
Transfected COS cells were labeled with [35S]sulfate as above, and 
the conditioned medium wassubjected to barium hydroxide hydrolysis 
as described by Huttner (1964). The following modifications were per- 
formed as described previously (Pittman et al., 1992). The “S-labeled 
conditioned medium was incubated with protein A-Sepharose, and 
the bound protein was run on a 12% SDS-polyacrylamide gel and 
transferred to Immobilon-P (Millipore). The filter was exposed to film, 
and the labeled band of interest was excised from the membrane and 
transferred to a Tuftainer (Pierce). Degassed 0.2 M barium hydroxide 
was added, and the tube was sealed under NP and baked for 16 hr 
at 110%. Following neutralization and lyophilization, the pellet was 
resuspended in 7.6% acetic acid, and 2.2% formic acid. We added 
5 ng each of unlabeled tyrosine sulfate and threonine sulfate to the 
sample to run as standards. The sample was spotted onto 20 x 20 
cm 100 Km cellulose thin-layer sheets (Kodak) and two-dimensional 
electrophoresis was performed. The standards were visualized with 
1% ninhydrin in acetone, and tyrosine [%]sulfate was detected by 
phosphorimager analysis (Fuji) and autoradiography. 
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